Literature DB >> 22191711

Revising the "Rule of Three" for inferring seizure freedom.

M Brandon Westover1, Justine Cormier, Matt T Bianchi, Mouhsin Shafi, Ronan Kilbride, Andrew J Cole, Sydney S Cash.   

Abstract

PURPOSE: How long after starting a new medication must a patient go without seizures before they can be regarded as seizure-free? A recent International League Against Epilepsy (ILAE) task force proposed using a "Rule of Three" as an operational definition of seizure freedom, according to which a patient should be considered seizure-free following an intervention after a period without seizures has elapsed equal to three times the longest preintervention interseizure interval over the previous year. This rule was motivated in large part by statistical considerations advanced in a classic 1983 paper by Hanley and Lippman-Hand. However, strict adherence to the statistical logic of this rule generally requires waiting much longer than recommended by the ILAE task force. Therefore, we set out to determine whether an alternative approach to the Rule of Three might be possible, and under what conditions the rule may be expected to hold or would need to be extended.
METHODS: Probabilistic modeling and application of Bayes' rule. KEY
FINDINGS: We find that an alternative approach to the problem of inferring seizure freedom supports using the Rule of Three in the way proposed by the ILAE in many cases, particularly in evaluating responses to a first trial of antiseizure medication, and to favorably-selected epilepsy surgical candidates. In cases where the a priori odds of success are less favorable, our analysis requires longer seizure-free observation periods before declaring seizure freedom, up to six times the average preintervention interseizure interval. The key to our approach is to take into account not only the time elapsed without seizures but also empirical data regarding the a priori probability of achieving seizure freedom conferred by a particular intervention. SIGNIFICANCE: In many cases it may be reasonable to consider a patient seizure-free after they have gone without seizures for a period equal to three times the preintervention interseizure interval, as proposed on pragmatic grounds in a recent ILAE position paper, although in other commonly encountered cases a waiting time up to six times this interval is required. In this work we have provided a coherent theoretical basis for modified criterion for seizure freedom, which we call the "Rule of Three-To-Six." Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22191711      PMCID: PMC3267849          DOI: 10.1111/j.1528-1167.2011.03355.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  9 in total

1.  Definition of refractory epilepsy: defining the indefinable?

Authors:  Patrick Kwan; Martin J Brodie
Journal:  Lancet Neurol       Date:  2009-11-13       Impact factor: 44.182

2.  Significance testing as perverse probabilistic reasoning.

Authors:  M Brandon Westover; Kenneth D Westover; Matt T Bianchi
Journal:  BMC Med       Date:  2011-02-28       Impact factor: 8.775

3.  If nothing goes wrong, is everything all right? Interpreting zero numerators.

Authors:  J A Hanley; A Lippman-Hand
Journal:  JAMA       Date:  1983-04-01       Impact factor: 56.272

4.  Effectiveness of first antiepileptic drug.

Authors:  P Kwan; M J Brodie
Journal:  Epilepsia       Date:  2001-10       Impact factor: 5.864

5.  Seizure outcome after temporal lobectomy: current research practice and findings.

Authors:  A M McIntosh; S J Wilson; S F Berkovic
Journal:  Epilepsia       Date:  2001-10       Impact factor: 5.864

6.  Identifying seizure clusters in patients with epilepsy.

Authors:  S R Haut; R B Lipton; A J LeValley; C B Hall; S Shinnar
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

7.  Early identification of refractory epilepsy.

Authors:  P Kwan; M J Brodie
Journal:  N Engl J Med       Date:  2000-02-03       Impact factor: 91.245

8.  Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies.

Authors:  Patrick Kwan; Alexis Arzimanoglou; Anne T Berg; Martin J Brodie; W Allen Hauser; Gary Mathern; Solomon L Moshé; Emilio Perucca; Samuel Wiebe; Jacqueline French
Journal:  Epilepsia       Date:  2009-11-03       Impact factor: 5.864

9.  Seizure frequency in intractable partial epilepsy: a statistical analysis.

Authors:  M Balish; P S Albert; W H Theodore
Journal:  Epilepsia       Date:  1991 Sep-Oct       Impact factor: 5.864

  9 in total
  6 in total

1.  Consensus Over Individualism: Validation of the ILAE Definition for Drug Resistant Epilepsy.

Authors:  Barbara C Jobst
Journal:  Epilepsy Curr       Date:  2015 Jul-Aug       Impact factor: 7.500

2.  Epilepsy Course and Developmental Trajectories in STXBP1-DEE.

Authors:  Ganna Balagura; Julie Xian; Antonella Riva; Francesca Marchese; Bruria Ben Zeev; Loreto Rios; Deepa Sirsi; Patrizia Accorsi; Elisabetta Amadori; Guja Astrea; Simona Baldassari; Francesca Beccaria; Antonella Boni; Mauro Budetta; Gaetano Cantalupo; Giuseppe Capovilla; Elisabetta Cesaroni; Valentina Chiesa; Antonietta Coppola; Robertino Dilena; Raffaella Faggioli; Annarita Ferrari; Elena Fiorini; Francesca Madia; Elena Gennaro; Thea Giacomini; Lucio Giordano; Michele Iacomino; Simona Lattanzi; Carla Marini; Maria Margherita Mancardi; Massimo Mastrangelo; Tullio Messana; Carlo Minetti; Lino Nobili; Amanda Papa; Antonia Parmeggiani; Tiziana Pisano; Angelo Russo; Vincenzo Salpietro; Salvatore Savasta; Marcello Scala; Andrea Accogli; Barbara Scelsa; Paolo Scudieri; Alberto Spalice; Nicola Specchio; Marina Trivisano; Michal Tzadok; Massimiliano Valeriani; Maria Stella Vari; Alberto Verrotti; Federico Vigevano; Aglaia Vignoli; Ruud Toonen; Federico Zara; Ingo Helbig; Pasquale Striano
Journal:  Neurol Genet       Date:  2022-05-31

3.  International veterinary epilepsy task force consensus proposal: outcome of therapeutic interventions in canine and feline epilepsy.

Authors:  Heidrun Potschka; Andrea Fischer; Wolfgang Löscher; Ned Patterson; Sofie Bhatti; Mette Berendt; Luisa De Risio; Robyn Farquhar; Sam Long; Paul Mandigers; Kaspar Matiasek; Karen Muñana; Akos Pakozdy; Jacques Penderis; Simon Platt; Michael Podell; Clare Rusbridge; Veronika Stein; Andrea Tipold; Holger A Volk
Journal:  BMC Vet Res       Date:  2015-08-28       Impact factor: 2.741

4.  Comparative effectiveness of antiepileptic drugs in juvenile myoclonic epilepsy.

Authors:  Katri Silvennoinen; Nikola de Lange; Sara Zagaglia; Simona Balestrini; Ganna Androsova; Merel Wassenaar; Pauls Auce; Andreja Avbersek; Felicitas Becker; Bianca Berghuis; Ellen Campbell; Antonietta Coppola; Ben Francis; Stefan Wolking; Gianpiero L Cavalleri; John Craig; Norman Delanty; Michael R Johnson; Bobby P C Koeleman; Wolfram S Kunz; Holger Lerche; Anthony G Marson; Terence J O'Brien; Josemir W Sander; Graeme J Sills; Pasquale Striano; Federico Zara; Job van der Palen; Roland Krause; Chantal Depondt; Sanjay M Sisodiya
Journal:  Epilepsia Open       Date:  2019-07-04

5.  The Korean Society for Neuro-Oncology (KSNO) Guideline for Antiepileptic Drug Usage of Brain Tumor: Version 2021.1.

Authors:  Chul Kee Park; Youn Soo Lee; Ho Shin Gwak; Jangsup Moon; Min Sung Kim; Young Zoon Kim; Kihwan Hwang; Ji Eun Park; Kyung Hwan Kim; Jin Mo Cho; Wan Soo Yoon; Se Hoon Kim; Young Il Kim; Ho Sung Kim; Yun Sik Dho; Jae Sung Park; Hong In Yoon; Youngbeom Seo; Kyoung Su Sung; Jin Ho Song; Chan Woo Wee; Min Ho Lee; Myung Hoon Han; Je Beom Hong; Jung Ho Im; Se Hoon Lee; Jong Hee Chang; Do Hoon Lim
Journal:  Brain Tumor Res Treat       Date:  2021-04

6.  Epilepsy Treatment Complacency in Patients, Caregivers, and Health Care Professionals.

Authors:  Patricia E Penovich; John M Stern; Danielle A Becker; Lucretia Long; Nancy Santilli; Lynanne McGuire; Eugenia Y Peck
Journal:  Neurol Clin Pract       Date:  2021-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.